Supplements

Nabiximols improves sleep disruption in multiple sclerosis patients

A systematic review and meta-analysis of 25 studies (2949 patients) found that nabiximols significantly reduced sleep disruption in MS patients (MD = -15.75; 95% CI = (-22.02)-(-9.49)). The evidence certainty was low to very low, and findings are considered exploratory.

Last updated: Jul 29, 2026•0 RCTs•1 Meta-analyses•📖 Read as article →

Evidence Score

Evidence Score49/100
Human RCT☆☆☆☆☆
Meta-analysis★★★☆☆
Mechanism★★★★★
Safety★★★★☆
Confidencelow

Study Evidence

Study 1. Nabiximols in Multiple Sclerosis: Beyond Spasticity-An Exploratory Systematic Review and Meta-Analysis of Symptomatic Outcomes.

observational

Kleiner D, Horváth IL, Mátis D, Nagy R, Gergő D, Lugosi K, Fazekas G, Fehérvári P, Hegyi P, Csupor D · Medical sciences (Basel, Switzerland) (2026)

Participants: N/A
Duration: N/A (not specified in abstract)
Intervention: Nabiximols (standardized Cannabis sativa extract) as add-on therapy
Outcome: Sleep disruption measured by change scores
Effect Size: MD = -15.75 (95% CI: -22.02 to -9.49)
Population: Adult patients with multiple sclerosis (MS) with moderate to severe spasticity

Result:

PubMed: 42506315DOI: 10.3390/medsci14030346

Mechanism Graph

Nabiximols binds to cannabinoid receptors (CB1 and CB2) in the central nervous system
↓
Modulation of neurotransmitter release reduces spasticity and associated symptoms
↓
Improved spasticity and pain may lead to better sleep quality
↓
Result: Reduced sleep disruption in MS patients

Limitations

  • ⚠Evidence certainty was low to very low
  • ⚠Findings are exploratory and not definitive
  • ⚠Time-dependency of effects was not significant

Frequently Asked Questions

What is nabiximols?▼

Nabiximols is a standardized extract of Cannabis sativa approved as add-on therapy for moderate to severe spasticity in multiple sclerosis.

How much does nabiximols improve sleep disruption?▼

The meta-analysis reported a mean difference of -15.75 (95% CI: -22.02 to -9.49) for sleep disruption, indicating significant improvement.

Is this evidence strong enough to recommend nabiximols for sleep problems in MS?▼

No, the evidence certainty was low to very low, so these findings are exploratory and not sufficient for clinical recommendations.

What other symptoms did nabiximols improve in this study?▼

Beyond sleep disruption, nabiximols also improved spasm quality, bladder function, and gait function in MS patients.

Products

Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.

References

  1. 1.Kleiner D, Horváth IL, Mátis D, Nagy R, Gergő D, Lugosi K, Fazekas G, Fehérvári P, Hegyi P, Csupor D. "Nabiximols in Multiple Sclerosis: Beyond Spasticity-An Exploratory Systematic Review and Meta-Analysis of Symptomatic Outcomes.." Medical sciences (Basel, Switzerland), 2026. PMID: 42506315 DOI: 10.3390/medsci14030346
Disclaimer: This content is for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.